This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ward, J. M. Articles by Devor, D. E. Search for Related Content PubMed PubMed Citation Articles by Ward, J. M. Articles by Devor, D. E. Social Bookmarking                         What's this?

Emerging Issues in Mouse Liver Carcinogenesis

Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, National Cancer Institute, Frederick, Maryland 21702-1201

Masa-Aki Shibata

Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, National Cancer Institute, Frederick, Maryland 21702-1201

Deborah E. Devor

Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, National Cancer Institute, Frederick, Maryland 21702-1201

The mouse liver is the primary target site for carcinogenesis of more than 200 chemicals (including pesticides. food additives, pharmaceuticals, and industrial intermediates) tested in long-term toxicity safety assessment assays. Mouse liver tumors develop through defined morphological stages (similar to those found in other species) whether their origin is of undetermined etiology (spontaneous) or induced by chemicals. The morphologic type of hepatocytes in the various stages of hepatocarcinogenesis is sometimes associated with the specific inducing agent. Liver tumors developing in toxic livers often have more benign appearances and may progress to carcinomas at a slower rate than tumors developing in histologically normal livers. Specific tumors, dependent on the inducing chemical, may regress under defined protocols. Genotoxic and nongenotoxic mouse hepatocarcinogens each may induce tumors of either high malignant or low malignant potential. Liver tumors with specific H-ras oncogene mutations may appear morphologically and biologically similar to those without proven ras mutations. Thus, distinguishing mechanism of carcinogenesis by liver tumor morphology and mutation spectra may be difficult. Additionally, the presence of liver tumors with a morphology and a ras oncogene mutation spectrum characteristic of spontaneous tumors in histologically normal livers of mice exposed to a nongenotoxic test chemical may indicate promotion of spontaneous hepatocarcinogenesis by one of several potential mechanisms. Further research into the mechanisms responsible for the increased incidences of liver tumors in mice exposed to test chemicals could enhance human cancer risk assessments.

Key Words: Hepatocarcinogenesis • bioassay • H-ras • nongenotoxic carcinogens • cell proliferation

Toxicologic Pathology, Vol. 24, No. 1, 129-137 (1996)
DOI: 10.1177/019262339602400117


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Kimura, M. Kawabe, A. Yu, H. Morishima, P. Fernandez-Salguero, G. J. Hammons, J. M. Ward, F. F. Kadlubar, and F. J. Gonzalez Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2 Carcinogenesis, March 1, 2003; 24(3): 583 - 587. [Abstract] [Full Text] [PDF]

				M. Takaoka, S. Sehata, T. Maejima, T. Imai, M. Tor, H. Satoh, K. Toyosawa, Z.-Y. Tanakamaru, T. Adachi, S. Hisada, et al. Interlaboratory Comparison of Short-Term Carcinogenicity Studies Using CB6F1-rasH2 Transgenic Mice Toxicol Pathol, February 1, 2003; 31(2): 191 - 199. [Abstract] [PDF]

				G. M. Gray, I. Linkov, M. Polkanov, and R. Wilson Liver adenomas and carcinomas: correlations and relationship to body weight in long-term rodent cancer bioassays Toxicology and Industrial Health, July 1, 2000; 16(6): 211 - 223. [Abstract] [PDF]

				J. I. Goodman, D. J. Brusick, W. M. Busey, S. M. Cohen, J. C. Lamb, and T. B. Starr Reevaluation of the Cancer Potency Factor of Toxaphene: Recommendations from a Peer Review Panel Toxicol. Sci., May 1, 2000; 55(1): 3 - 16. [Abstract] [Full Text] [PDF]

				S. Kimura, M. Kawabe, J. M. Ward, H. Morishima, F. F. Kadlubar, G. J. Hammons, P. Fernandez-Salguero, and F. J. Gonzalez CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice Carcinogenesis, September 1, 1999; 20(9): 1825 - 1830. [Abstract] [Full Text] [PDF]